Pharma
CFOCRE

Pharma Company Achieves Scope 3 Reporting with Verified Data

A mid-sized pharmaceutical firm needed verifiable energy data for their ESG reporting. Their old building couldn't provide it.

"We went from 'best guess' ESG numbers to auditor-verified data. That's the difference between compliance and credibility."

Tenant, VP Finance & Sustainability

Company Profile

Industry
Pharmaceutical
Size
180 employees
Geneva Footprint
2,100 sqm
Years at LINK
2 years

Before & After

ESG Data Quality
Before

Annual totals only, no granular breakdown

After

250+ sub-meters, real-time data access

Reporting Time
Before

Weeks to compile estimates for auditors

After

Monthly data ready on demand

Energy Cost Variance
Before

±15% budget variance, surprises every quarter

After

±2% variance, predictable costs

Audit Readiness
Before

Scrambling before every ESG audit

After

First Geneva office to meet new CSRD requirements

Decision Drivers by Role

Different stakeholders have different priorities. Here's what mattered most to each role—and what they achieved.

CFO
Key Driver

New EU sustainability regulations (CSRD) required verifiable Scope 3 data

Outcome

Passed ESG audit with commendation

CRE
Key Driver

Previous landlord couldn't provide granular energy consumption data

Outcome

LINK's 250+ sub-meters delivered exactly what was needed

Measurable Results

Passed
ESG Audit
First Geneva office to meet new requirements
±2%
Energy Cost Variance
vs. ±15% in previous building
-80%
Reporting Time
Monthly data vs. annual estimates

More Tenant Stories

View All →
Explore more stories from tenants across finance, technology, NGOs, and more.

Ready to Write Your Own Story?

Tour the building. Meet current tenants. See for yourself why companies like this one chose LINK.